content:self_limited_epilepsy_with_centrotemporal_spikes_selects

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
content:self_limited_epilepsy_with_centrotemporal_spikes_selects [2024/03/23 19:39] – [Treatment] biju.hameed@gmail.comcontent:self_limited_epilepsy_with_centrotemporal_spikes_selects [2024/03/23 19:44] (current) – [Treatment] biju.hameed@gmail.com
Line 53: Line 53:
  
 ==== Treatment ==== ==== Treatment ====
 +
   * As the seizures associated with SeLECTS often stop around the age of puberty, it is not clear whether it is necessary to prescribe ASMs to all children who present with this condition.   * As the seizures associated with SeLECTS often stop around the age of puberty, it is not clear whether it is necessary to prescribe ASMs to all children who present with this condition.
   * When considering the use of antiseizure medications for SeLECTS, it is important to have a thorough discussion with the individual, their family, and caregivers (if applicable). This discussion should focus on developing a personalized medication strategy based on the specific epilepsy syndrome, treatment objectives, and the preferences of the individual and their family or caregivers.   * When considering the use of antiseizure medications for SeLECTS, it is important to have a thorough discussion with the individual, their family, and caregivers (if applicable). This discussion should focus on developing a personalized medication strategy based on the specific epilepsy syndrome, treatment objectives, and the preferences of the individual and their family or caregivers.
-  * lamotrigine and levetiracetam should be considered as first-line treatment[(:cite:978-1-4731-4513-9>National Guideline Alliance (UK). Effectiveness of antiseizure medications for self-limited epilepsy with centrotemporal spikes: Epilepsies in children, young people and adults: Evidence review Q. London: National Institute for Health and Care Excellence (NICE); 2022 Apr. (NICE Guideline, No. 217.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK581163/)]+  * lamotrigine and levetiracetam should be considered as first-line treatment[(:cite:978-1-4731-4513-9>National Guideline Alliance (UK). Effectiveness of antiseizure medications for self-limited epilepsy with centrotemporal spikes: Epilepsies in children, young people and adults: Evidence review Q. London: National Institute for Health and Care Excellence (NICE); 2022 Apr. (NICE Guideline, No. 217.) Available from: [[https://www.ncbi.nlm.nih.gov/books/NBK581163/]])]
   * As second-line treatment, carbamazepine, oxcarbazepine and zonisamide are recommended   * As second-line treatment, carbamazepine, oxcarbazepine and zonisamide are recommended
-  * school performance is a good indicator of cognition since it measures processing and retention.If any deterioration is noted, an EEG should be performed to exclude electrical status epilepticus in sleep (ESES)continuous spike-wave of slow-wave sleep (CSWS). A neuropsychology assessment to review academic performance should also be performed.+  * school performance is a good indicator of cognition since it measures processing and retention.If any deterioration is noted, an EEG should be performed to exclude [[content:developmental_and:or_epileptic_encephalopathy_with_spike-wave_activation_in_sleep_d:ee-swas|Developmental and/or epileptic encephalopathy with spike-wave activation in sleep D/EE-SWAS]]. A neuropsychology assessment to review academic performance should also be performed. 
  
 ==== References ==== ==== References ====
  
  
  • content/self_limited_epilepsy_with_centrotemporal_spikes_selects.txt
  • Last modified: 2024/03/23 19:44
  • by biju.hameed@gmail.com